Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation.
about
Herpesviruses and chromosomal integrationDetection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitisHHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipientsHuman herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation.Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cellsHuman herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9.Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults.Simultaneous human herpesvirus 6-associated encephalitis and Guillain-Barré syndrome in a patient after matched unrelated donor haematopoietic stem cell transplantationCNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.Central nervous system infections in immunocompromised patients: update on diagnostics and therapy.Effect of (r)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and AZT-lipid-PFA on human herpesvirus-6B infected cellsHHV-6 encephalitis in pediatric unrelated umbilical cord transplantation: a role for ganciclovir prophylaxis?Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.Opportunistic infections of the central nervous system in the transplant patient.Encephalitis caused by human herpesvirus-6B in pancreas-after-kidney transplantation.Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation.Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review.Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34+ Selected Hematopoietic Cell Transplantation.Human Herpesvirus 6B Induces Hypomethylation on Chromosome 17p13.3, Correlating with Increased Gene Expression and Virus Integration.Detection of DNA of six human herpesviruses in the cerebrospinal fluid of immunocompetent non-herpetic acute limbic encephalitis patients.Animal models for human herpesvirus 6 infection.Analysis of five cases of human herpesvirus-6 myelitis among 121 cord blood transplantations.Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum.Multicenter external quality assessment of molecular methods for detection of human herpesvirus 6.Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation.Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation.High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia.Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients.Human herpesvirus-6 encephalitis following chemotherapy induction for acute myelogenous leukemia.Genomic Integration of HHV-6 Mimicking Viral Reactivation after Autologous Stem Cell Transplantation.Relationship between beta-herpesviruses reactivation and development of complications after autologous peripheral blood stem cell transplantation.Human Herpesvirus 6 and Neuroinflammation
P2860
Q24610959-A163D6A3-C79C-41F7-9025-3A79A6F84CC7Q27488291-068779A2-867C-44F4-80C7-F6A667B7AA57Q28743914-2B2C4643-F208-4745-BE9E-3C7BA67BF06FQ30604692-61E4A269-755C-4EC2-8639-73AD88CC7473Q33301426-CCDED039-5962-4F0F-BD8E-4F940DD30354Q33602699-95D616D9-C03E-4377-AF97-6D4D03FB40D9Q33897804-E702E336-99CF-4B62-B3DC-085BA70E928AQ34537814-BEAB2912-FC69-4108-83BA-910478639D28Q35752239-B25BCF24-3883-428C-BD54-3DD6495E2711Q35762061-12333633-DC82-47B9-8DD3-8B7ACF3DD23DQ37041199-85E9B9D3-81E3-48F5-BB73-4BEBB2B0EC0DQ37276889-228D1A38-CEB5-4AAB-9751-C26E1826850CQ37334159-2B02251E-AFC6-45F1-A2A4-F2E784F1248EQ37561897-64541677-C539-4024-92CB-AE8F91D0314CQ37618303-5568C9EF-7B61-431F-AF21-95FC938DAFD5Q38002109-F30A16DF-7AEE-4E66-BD3C-904459F595B7Q38123749-77246407-CD72-4862-AD18-4ADAB31C6055Q38231549-39217BFC-99B0-4AED-97E9-45C36782E331Q38444117-97077EB5-262B-4BD0-8FFD-413B8EF9482FQ38637173-48D44329-CD65-4408-AAC9-3CE52EBF1BE3Q40087415-9F3FCA29-94D9-498C-92A2-7601851175CDQ40138389-7DAC3E85-669A-4A35-B606-8C32BB784968Q40290373-DE501A2E-E1A2-4421-B663-B2E14F3C3B95Q40353289-BE114165-A885-4D33-86B5-468CCC0A1B80Q41845061-2AD84708-08B0-4A0F-88C3-1C2847075DD9Q41922094-00B28AAB-C8B3-498D-B029-C02F16B33927Q42027059-734FBE3C-65C1-4C9B-ABD3-D5E87A3690D4Q42228544-3DF868DA-43C1-48BE-A0B1-19DA97C56083Q43537600-EAEA2B49-2F12-4295-ABF2-E758BCB4953DQ43971471-683DA211-E7D7-4546-A686-5192A83A047FQ44189939-D8670743-1856-44A4-8D55-86C25686B1CAQ44994852-BC20122A-368C-4A89-BF43-AE4A4A5F2FB1Q45368979-2FEB0FA6-4756-474D-B57B-7C0AC7C3A7EBQ47436824-CFC194F6-F775-41CA-81E6-816915AA6B33Q47733733-F6AE5720-71B2-48EE-B4D7-C3DA38E2DD2FQ48178536-62E40D19-7E63-4CBF-A778-02416F3A072BQ52659308-24EDB13F-5474-4B99-A433-4FE2199A2E3CQ54286870-E7942EF5-D367-4F45-9606-84BD4A8917B3Q58999748-3143A0F5-5A60-4E80-B93E-117A58E4AC87
P2860
Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Human herpesvirus 6 and centra ...... opoietic cell transplantation.
@ast
Human herpesvirus 6 and centra ...... opoietic cell transplantation.
@en
type
label
Human herpesvirus 6 and centra ...... opoietic cell transplantation.
@ast
Human herpesvirus 6 and centra ...... opoietic cell transplantation.
@en
prefLabel
Human herpesvirus 6 and centra ...... opoietic cell transplantation.
@ast
Human herpesvirus 6 and centra ...... opoietic cell transplantation.
@en
P1476
Human herpesvirus 6 and centra ...... opoietic cell transplantation.
@en
P2093
Danielle M Zerr
P356
10.1016/S1386-6532(06)70012-9
P478
37 Suppl 1
P577
2006-12-01T00:00:00Z